Patent · US Active

Anti-complement factor C1q antibodies and uses thereof

US10227398B2 · kind B2 · utility

5Cited by
3References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 19, 2017
Grant dateMar 12, 2019
Priority date
Expiry dateApr 19, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/4716
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides anti-C1q antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.